Wide and Cystic Brain Metastases Reveal RET-Rearranged Non-Small-Cell Lung Cancers

被引：6

作者：

Facchinetti, Francesco ^{[1
,2
]}

Bozzetti, Francesca ^{[1
]}

Gnetti, Letizia ^{[1
]}

Minari, Roberta ^{[1
]}

Crafa, Pellegrino ^{[1
]}

Rebuzzi, Sara Elena ^{[1
]}

Ferrara, Roberto ^{[3
]}

Gruppioni, Elisa ^{[4
]}

Capizzi, Elisa ^{[4
]}

Giombelli, Ermanno ^{[1
]}

Crisi, Girolamo ^{[1
]}

Altimari, Annalisa ^{[4
]}

Tiseo, Marcello ^{[1
,5
]}

机构：

[1] Univ Hosp Parma, Parma, Italy

[2] Univ Paris Saclay, Villejuif, France

[3] Ist Nazl Tumori, Milan, Italy

[4] St Orsola Malpighi Hosp, Bologna, Italy

[5] Univ Parma, Parma, Italy

来源：

JCO PRECISION ONCOLOGY | 2019年 / 3卷

关键词：

RADIOSURGERY;

D O I：

10.1200/PO.19.00073

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1 / 7

页数：7

共 50 条

[31] Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer
Xu, Yi-Bing
Zhang, Yiping
Song, Zhengbo
Wang, Wenxian
Shao, Lan
CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6309 - 6317
[32] Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers.
Drilon, Alexander E.
Sima, Camelia S.
Somwar, Romel
Smith, Roger
Ginsberg, Michelle S.
Riely, Gregory J.
Rudin, Charles M.
Ladanyi, Marc
Kris, Mark G.
Rizvi, Naiyer A.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[33] Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers
Drilon, A.
Bergagnini, I.
Delasos, L.
Sabari, J.
Woo, K. M.
Plodkowski, A.
Wang, L.
Hellmann, M. D.
Joubert, P.
Sima, C. S.
Smith, R.
Somwar, R.
Rekhtman, N.
Ladanyi, M.
Riely, G. J.
Kris, M. G.
ANNALS OF ONCOLOGY, 2016, 27 (07) : 1286 - 1291
[34] MDM2 Amplification Mediates Resistance to Cabozantinib in RET-Rearranged Lung Cancers
Ishizawa, Kota
Horii, Akira
Romel, R.
Cheng, E.
Drilon, A.
CANCER SCIENCE, 2018, 109 : 351 - 351
[35] Clinical Outcomes with Pemetrexed-Based Systemic Therapy in RET-Rearranged Lung Cancers
Drilon, Alexander
Bergagnini, Isabella
Delasos, Lukas
Sima, Camelia S.
Smith, Roger
Somwar, Romel
Riely, Gregory J.
Kris, Mark G.
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S178 - S178
[36] Non-Small-Cell Lung Cancer and Brain Metastases in Brazil
Weis, Luiza N.
Coelho, Juliano C.
Marks, Patricia
Geib, Guilherme
Liedke, Pedro
Pereira, Rodrigo
Schwartsmann, Gilberto
Azevedo, Sergio
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S204 - S205
[37] Management of Brain Metastases in Non-Small-Cell Lung Cancer
Ernani, Vinicius
Stinchcombe, Thomas E.
JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (11) : 563 - +
[38] MIG6 loss increased RET inhibitor tolerant persister cells in RET-rearranged non-small cell lung cancer
Wei, Xinzhao
Uchibori, Ken
Kondo, Nobuyuki
Utsumi, Takahiro
Takemoto, Ai
Koike, Sumie
Takagi, Satoshi
Yanagitani, Noriko
Nishio, Makoto
Katayama, Ryohei
CANCER LETTERS, 2024, 604
[39] Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial
Yoh, Kiyotaka
Seto, Takashi
Satouchi, Miyako
Nishio, Makoto
Yamamoto, Noboru
Murakami, Haruyasu
Nogami, Naoyuki
Matsumoto, Shingo
Kohno, Takashi
Tsuta, Koji
Tsuchihara, Katsuya
Ishii, Genichiro
Nomura, Shogo
Sato, Akihiro
Ohtsu, Atsushi
Ohe, Yuichiro
Goto, Koichi
LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : 42 - 50
[40] Machine-Learning-Aided Prediction of Brain Metastases Development in Non-Small-Cell Lung Cancers
Visona, Giovanni
Spiller, Lisa M.
Hahn, Sophia
Hattingen, Elke
Schweikert, Gabriele
Bankov, Katrin
Demes, Melanie
Reis, Henning
Wild, Peter
Zeiner, Pia S.
Acker, Fabian
Sebastian, Martin
Wenger, Katharina J.
Vogl, Thomas J.
CLINICAL LUNG CANCER, 2023, 24 (08) : E311 - E322

← 1 2 3 4 5 →